DALLAS, Sept. 28, 2022 /PRNewswire/ — Susan G. Komen®, the world’s leading breast cancer organization, and GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, are partnering for the first time to support the Susan G Komen’s Metastatic Breast Cancer (MBC) Impact Series.
To read the full press release, click here:
Leave a Reply